These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35483386)

  • 1. CDKL5 deficiency disorder: clinical features, diagnosis, and management.
    Leonard H; Downs J; Benke TA; Swanson L; Olson H; Demarest S
    Lancet Neurol; 2022 Jun; 21(6):563-576. PubMed ID: 35483386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.
    Olson HE; Daniels CI; Haviland I; Swanson LC; Greene CA; Denny AMM; Demarest ST; Pestana-Knight E; Zhang X; Moosa AN; Fidell A; Weisenberg JL; Suter B; Fu C; Neul JL; Percy AK; Marsh ED; Benke TA; Poduri A
    J Neurodev Disord; 2021 Sep; 13(1):40. PubMed ID: 34530725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
    Amin S; Møller RS; Aledo-Serrano A; Arzimanoglou A; Bager P; Jóźwiak S; Kluger GJ; López-Cabeza S; Nabbout R; Partridge CA; Schubert-Bast S; Specchio N; Kälviäinen R
    Epilepsia Open; 2024 Jun; 9(3):832-849. PubMed ID: 38450883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
    Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
    Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
    Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
    Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
    Hong W; Haviland I; Pestana-Knight E; Weisenberg JL; Demarest S; Marsh ED; Olson HE
    CNS Drugs; 2022 Jun; 36(6):591-604. PubMed ID: 35633486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
    Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
    Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
    Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
    Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.
    Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A
    Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).
    Saldaris J; Leonard H; Jacoby P; Marsh ED; Benke TA; Demarest S; Downs J
    J Child Neurol; 2022 May; 37(6):541-547. PubMed ID: 35422141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.
    Daniels C; Greene C; Smith L; Pestana-Knight E; Demarest S; Zhang B; Benke TA; Poduri A; Olson HE;
    Dev Med Child Neurol; 2024 Apr; 66(4):456-468. PubMed ID: 37771170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.
    Leonard H; Junaid M; Wong K; Demarest S; Downs J
    Epilepsy Res; 2021 Jan; 169():106521. PubMed ID: 33341033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
    Olson HE; Demarest ST; Pestana-Knight EM; Swanson LC; Iqbal S; Lal D; Leonard H; Cross JH; Devinsky O; Benke TA
    Pediatr Neurol; 2019 Aug; 97():18-25. PubMed ID: 30928302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic.
    Kadam SD; Sullivan BJ; Goyal A; Blue ME; Smith-Hicks C
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31618813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report of Tunisian patients with CDKL5-related encephalopathy.
    Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F
    Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy.
    Dell'Isola GB; Fattorusso A; Pisani F; Mastrangelo M; Cordelli DM; Pavone P; Parisi P; Ferretti A; Operto FF; Elia M; Carotenuto M; Pruna D; Matricardi S; Spezia E; Spalice A; Scorrano G; Savasta S; Prontera P; Di Cara G; Fruttini D; Salpietro V; Striano P; Verrotti A
    J Neurol; 2024 Aug; 271(8):5368-5377. PubMed ID: 38874638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKL5 deficiency disorder in males: Five new variants and review of the literature.
    Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E
    Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.
    Tangarorang J; Leonard H; Epstein A; Downs J
    Am J Med Genet A; 2019 Feb; 179(2):249-256. PubMed ID: 30561084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder.
    Massey S; Quigley A; Rochfort S; Christodoulou J; Van Bergen NJ
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKL5 deficiency disorder: a pathophysiology of neural maintenance.
    Kind PC; Bird A
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.